Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A look at highlights from the 2018 Liver Meeting focusing on nonalcoholic fatty liver disease.
Updated hepatitis C recommendations emphasize screening for key populations and treatment for all people living with HCV.
Clinical trial findings from the 2017 Liver Meeting
Hepatitis C treatment has improved dramatically in recent years.
Five Liver Meeting takeaways for viral hepatitis advocates in the United States.
AASLD is the leading scientific and professional organization in the U.S. committed to preventing and curing liver disease
Elbasvir/grazoprevir cured high rates of individuals with genotypes 1, 4 or 6 of hepatitis C who inject drugs and are receiving opioid agonist...
Daklinza (daclatasvir) and Sovaldi (sofosbuvir) plus ribavirin cured high rates of people with genotype 3 of hepatitis C and advanced fibrosis...
The American Association for the Study of Liver Diseases has updated the treatment guidelines for hepatitis C.
Physicians increasingly argue that the best choice is to get rid of hepatitis C right away. But insurers may deny you. How risky is it to wait...
Over 1 million Americans diagnosed with hepatitis C have advanced enough disease to meet the ’high’ or ’highest’ priority status for treatment...
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America have issued a new chapter of their hep...
Guidelines for hepatitis C have updated once again to emphasize that those with advanced fibrosis or compensated cirrhosis should be treated f...
Twelve weeks of Gilead Sciences’ Harvoni cured high rates of genotypes 3 and 6 of hepatitis C virus, with and without ribavirin.
Twelve or 18 weeks of Merck?s grazoprevir/elbasvir, with or without ribavirin, cured 91 to 100 percent of hard-to-treat people with genotype 1...
Hep C treatment guidelines have been revised to underline that treatment will benefit almost all HCV-positive people, regardless of disease se...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.